Liver Transplantation in France
- PMID: 30697904
- DOI: 10.1002/lt.25419
Liver Transplantation in France
Abstract
In France, the main indications for liver transplantation are hepatocellular carcinoma (HCC) and alcoholic cirrhosis. The number of candidates for decompensated hepatitis C virus-related cirrhosis has markedly decreased since the advent of direct-acting antiviral agents. Nonalcoholic steatohepatitis represents a lower proportion of candidates as compared with the United States. The main source of donors is donation after brain death, but the program of transplantation using donation after circulatory death is growing with excellent results. The deceased donation rate was 28.8 per million people in 2017, which has increased over the last few years. Adult-to-adult living donor liver transplantation has been almost completely abandoned. Donors are allocated on a national basis, and there is no longer local or regional priority. In patients with decompensated cirrhosis, prioritization is based on the Model for End-Stage Liver Disease (MELD) score. The distance between the donor and the recipient is taken into account according to an original gravity model. In patients with HCC, prioritization depends on the alfa-fetoprotein (AFP) score, the MELD score, and waiting time. Only patients with HCC tumor-node-metastasis ≥2 and AFP score ≤2 are eligible for the HCC score. A list of MELD exceptions, consisting of uncommon complications where mortality risk is not adequately predicted by the MELD score and conditions other than cirrhosis, has been established. MELD exceptions must be individually validated by a college of experts mandated by the French Regulatory Agency of Transplantation (Agence de la Biomédecine). The most common MELD exception is refractory ascites with a low MELD score. A major challenge is to reduce the rate of refusal of donation through information campaigns.
Copyright © 2019 by the American Association for the Study of Liver Diseases.
Similar articles
-
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.Liver Transpl. 2011 Oct;17(10):1137-51. doi: 10.1002/lt.22363. Liver Transpl. 2011. PMID: 21695771 Review.
-
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.J Hepatol. 2014 Feb;60(2):290-7. doi: 10.1016/j.jhep.2013.10.010. Epub 2013 Oct 23. J Hepatol. 2014. PMID: 24161408
-
MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.Liver Transpl. 2015 May;21(5):612-22. doi: 10.1002/lt.24098. Epub 2015 Apr 15. Liver Transpl. 2015. PMID: 25694099
-
Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.Ann Surg. 2011 Nov;254(5):745-53; discussion 753. doi: 10.1097/SLA.0b013e3182365081. Ann Surg. 2011. PMID: 22042468
-
Current Status of Simultaneous Liver-Kidney Transplantation in the United States.Liver Transpl. 2019 May;25(5):797-806. doi: 10.1002/lt.25444. Epub 2019 Apr 3. Liver Transpl. 2019. PMID: 30861294 Review.
Cited by
-
Solid Organ Transplant Litigation at One of Europe's Largest University Hospitals.Transpl Int. 2024 May 1;37:12439. doi: 10.3389/ti.2024.12439. eCollection 2024. Transpl Int. 2024. PMID: 38751770 Free PMC article.
-
Impact of the COVID-19 pandemic on liver transplant waitlist outcome in France.Sci Rep. 2023 Jun 8;13(1):9308. doi: 10.1038/s41598-023-32680-8. Sci Rep. 2023. PMID: 37291177 Free PMC article.
-
Current Approaches in the Allocation of Liver Transplantation.J Pers Med. 2022 Oct 6;12(10):1661. doi: 10.3390/jpm12101661. J Pers Med. 2022. PMID: 36294801 Free PMC article. Review.
-
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors.Curr Treat Options Oncol. 2023 Nov;24(11):1651-1665. doi: 10.1007/s11864-023-01124-w. Epub 2023 Oct 26. Curr Treat Options Oncol. 2023. PMID: 37882889 Free PMC article. Review.
-
Preservation of Organs to Be Transplanted: An Essential Step in the Transplant Process.Int J Mol Sci. 2022 Apr 30;23(9):4989. doi: 10.3390/ijms23094989. Int J Mol Sci. 2022. PMID: 35563381 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical